Research front maps are diagrammatic representations of the core papers
comprising each front. They are selected from the current Research Front set
that are relevant to the featured special topic. The title for this Research
Front Map is "INSULIN TREATMENT OF TYPE 2 DIABETES," containing
17 core papers. Source dates: 1999-February 28, 2009 (first bimonthly
period 2009).
Each circle represents a highly cited paper whose bibliographic information
is displayed when the user clicks on the circle. The solid lines between circles
represent the strongest co-citation links for each paper (that is, indicating
that the papers are frequently cited together); weaker links are indicated by
dashed lines. Papers close to each other on the map are generally more highly
co-cited. The most recent paper(s) are indicated in pink. Annotations may have
been added to this map which represent the main research themes. These appear as
labels attached to specific regions on the maps.
Note: For best results use the
"landscape orientation" option when printing this page.
Core
Papers
Label: Riddle-2003 Title: The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Journal: DIABETES CARE, 26 (11): 3080-3086 NOV 2003 Citations: 309 Authors: Riddle, MC;Rosenstock, J;Gerich, J;Insulin Glargine 4002 Study Invest Addresses:
Oregon Hlth & Sci Univ, Sect Diabet L 345, 3181 SW Sam Jackson, Portland, OR 97201 USA
Oregon Hlth & Sci Univ, Sect Diabet L 345, Portland, OR 97201 USA
Dallas Diabet & Endocrine Ctr, Dallas, TX USA
Univ Rochester, Ctr Med, Rochester, NY USA
Label: Monnier-2003 Title: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients - Variations with increasing levels of HbA(1c) Journal: DIABETES CARE, 26 (3): 881-885 MAR 2003 Citations: 246 Authors: Monnier, L;Lapinski, H;Colette, C Addresses:
Lapeyronie Hosp, Dept Metab, F-34295 Montpellier 5, France
Lapeyronie Hosp, Dept Metab, F-34295 Montpellier 5, France
Univ Inst Clin Res, Montpellier, France
Label: Raskin-2005 Title: Initiating insulin therapy in type 2 diabetes - A comparison of biphasic and basal insulin analogs Journal: DIABETES CARE, 28 (2): 260-265 FEB 2005 Citations: 164 Authors: Raskin, P;Hu, P;Allen, E;Bode, B;Hollander, P;Garber, A;Lewin, A;Gabbay, RA;INITIATE Study Grp Addresses:
Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
Novo Nordisk, Princeton, NJ USA
Baylor Univ, Med Ctr, Dallas, TX USA
Natl Res Inst, Los Angeles, CA USA
Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Hershey, PA 17033 USA
Atlanta Diabet Assoc, Atlanta, GA USA
Baylor Coll Med, Houston, TX 77030 USA
Label: Haak-2005 Title: Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes Journal: DIABETES OBES METAB, 7 (1): 56-64 JAN 2005 Citations: 80 Authors: Haak, T;Tiengo, A;Draeger, E;Suntum, M;Waldhausl, W Addresses:
Diabet Acad Mergentheim, Res Inst, Theodor Klotzbucher Str 12, D-97980 Bad Mergentheim, Germany
Diabet Acad Mergentheim, Res Inst, D-97980 Bad Mergentheim, Germany
Univ Padua, Sch Med, Dept Clin & Expt Med, Padua, Italy
Novo Nordisk AS, Gladsaxe, Denmark
Med Unv Vienna, Dept Med 3, Vienna, Austria
Label: Yki-Jarvinen-2006 Title: Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study Journal: DIABETOLOGIA, 49 (3): 442-451 MAR 2006 Citations: 70 Authors: Yki-Jarvinen, H;Kauppinen-Makelin, R;Tiikkainen, M;Vahatalo, M;Virtamo, H;Nikkila, K;Tulokas, T;Hulme, S;Hardy, K;McNulty, S;Hanninen, J;Levanen, H;Lahdenpera, S;Lehtonen, R;Ryysy, L Addresses:
Univ Helsinki, Dept Med, POB 340, FIN-00029 Helsinki, Finland
Univ Helsinki, Dept Med, FIN-00029 Helsinki, Finland
Jorvi Hosp, SF-02740 Espoo, Finland
City Turku Hlth Ctr, Turku, Finland
Lappi Cent Hosp, Rovaniemi, Finland
Whiston Hosp, Prescot, England
Mikkeli Hlth Ctr, Mikkeli, Finland
Sanofi Aventis, Helsinki, Finland
Kymenlaakso Cent Hosp, Kotka, Finland
Label: Rosenstock-2006 Title: Triple therapy in type 2 diabetes - Insulin glargine or rosiglitazone added to combmiation therapy of sulfonylurea plus metformin in insulin-naive patients Journal: DIABETES CARE, 29 (3): 554-559 MAR 2006 Citations: 49 Authors: Rosenstock, J;Sugimoto, D;Strange, P;Stewart, JA;Soltes-Rak, E;Dailey, G;Insulin Glargine 4014 Study Invest Addresses:
Dallas Diabet & Endocrine Ctr Med City, 7777 Forest Ln,C-618, Dallas, TX 75230 USA
Dallas Diabet & Endocrine Ctr Med City, Dallas, TX 75230 USA
Cedar Crosse Res Ctr, Chicago, IL USA
Aventis Pharmaceut, Bridgewater, NJ USA
Aventis Pharma, Quebec City, PQ, Canada
Diabet & Endocrinol Scripps Clin, La Jolla, CA USA
Label: Garber-2006 Title: Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study) Journal: DIABETES OBES METAB, 8 (1): 58-66 JAN 2006 Citations: 48 Authors: Garber, AJ;Wahlen, J;Wahl, T;Bressler, P;Braceras, R;Allen, E;Jain, R Addresses:
Baylor Coll Med, BCM Fac Ctr, 1709 Dryden Rd,Suite 1000, Houston, TX 77030 USA
Baylor Coll Med, BCM Fac Ctr, Houston, TX 77030 USA
Endocrine Res Specialists, Ogden, UT USA
Internal Med Assoc Res Ctr, Omaha, NE USA
Endocrine & Diabet Assoc, Dallas, TX USA
Novo Nordisk AS, Princeton, NJ USA
Adv Healthcare, Milwaukee Med Clin, Milwaukee, WI USA
Label: Bretzel-2008 Title: Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial Journal: LANCET, 371 (9618): 1073-1084 MAR-APR 2008 Citations: 20 Authors: Bretzel, RG;Nuber, U;Landgraf, W;Owens, DR;Bradley, C;Linn, T Addresses:
Univ Giessen, Med Klin & Poliklin 3, Rodthohl 6, D-35392 Giessen, Germany
Univ Giessen, Med Klin & Poliklin 3, D-35392 Giessen, Germany
Sanofi Aventis Deutschland GmbH, Med Affairs, Berlin, Germany
Llandough Univ Hosp, Diabet Res Unit, Cardiff, Wales
Univ London Royal Holloway & Bedford New Coll, Surrey, England
Label: Rosenstock-2008 Title: A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes Journal: DIABETOLOGIA, 51 (3): 408-416 MAR 2008 Citations: 11 Authors: Rosenstock, J;Davies, M;Home, PD;Larsen, J;Koenen, C;Schernthaner, G Addresses:
Dallas Diabet & Endocrine Ctr Med City, 7777 Forest Lane C-685, Dallas, TX 75230 USA
Dallas Diabet & Endocrine Ctr Med City, Dallas, TX 75230 USA
Univ Leicester, Cardiovasc Sci Dept, Leicester, Leics, England
Univ Newcastle, Sch Med Sci, Newcastle Upon Tyne, Tyne & Wear, England
Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
Rudolfstiftung Hosp Vienna, Dept Med, Vienna, Austria